On 16 April 2024, XECAN, a leading innovator in advanced oncology solutions assisted by artificial intelligence, presents an AI Lung Cancer Prediction tool. The goal of this tool is to enhance early detection and intervention, as early diagnosis often improves treatment outcomes. By identifying individuals at a higher risk of developing lung cancer, healthcare providers can tailor screening programs and preventive measures to potentially reduce the impact of the disease.
What sets it apart is its ability to detect potential risks at an earlier stage compared to human doctors, thereby significantly mitigating the need for unnecessary biopsies. This not only ensures a more streamlined and cost-effective diagnostic process but also alleviates patient anxiety and discomfort associated with unnecessary medical procedures.
The XECAN Lung Screen tool stands out as a groundbreaking solution, leveraging the advanced capabilities of the Sybil lung screen AI model. This innovative technology provides a swift and comprehensive risk prediction for lung cancer, spanning a significant 1-6 year timeframe, all achieved through the simplicity of a single CT scan.
Sybil was collaboratively developed by MIT's Abdul Latif Jameel Clinic for Machine Learning in Health, the Mass General Cancer Center (MGCC), and Chang Gung Memorial Hospital (CGMH). Sybil has undergone validation using three independent datasets: a set of 6,282 LDCTs from NLST participants, 8,821 LDCTs from Massachusetts General Hospital (MGH), and 12,280 LDCTs from Chang Gung Memorial Hospital (CGMH), including individuals with diverse smoking histories, including nonsmokers. The Sybil model aims to predict short and long-term lung cancer risk based on a single LDCT upload, without the need for additional clinical data or radiologist annotations. Deep Learning Based Predictor of Future Lung Cancer Risk Sybil is currently not FDA-approved and is intended for utilization in testing and research endeavors.
XECAN intends to retrain Sybil with more LDCT images. If you're interested in utilizing the XECAN Lung Screen tool and helping to improve the model. please let us know.
The AI model can be accessed online by sending email to info@xecan.com
About XECAN: XECAN provides AI-assisted clinic solutions to improve clinic workflow, patient tracking, treatment safety, and overall quality of patient care. With a focus on innovation and personalized care, XECAN's mission is to enhance the healthcare experience for both patients and healthcare providers.